The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Amoxicillin And Clavulanate Potassium
amoxicillin and clavulanate potassium · AMOXICILLIN 600 mg/5mL; CLAVULANATE POTASSIUM 42.9 mg/5mL · For Suspension · Oral · Redpharm Drug
NDC 67296-1921-07 · 75 mL in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 81964-0003-54) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$4.48per unit
middle half $4.47–$4.69 · 16 plans · Jul 1, 2024
Est. net of rebatesⓘ
≈ $4.48
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
—of plans cover it
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 3 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for amoxicillin and clavulanate potassium (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- RedPharm DrugUnited Statesrepack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA050755
- TE code
- AB
- Approval date
- Jun 22, 2001
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of amoxicillin and clavulanate potassium (For Suspension)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Allegis Holdings, LLC | AMOXICILLIN 125 mg/5mL; CLAVULANATE POTASSIUM 31.25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | AMOXICILLIN 600 mg/5mL; CLAVULANATE POTASSIUM 42.9 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Redpharm Drug | AMOXICILLIN 600 mg/5mL; CLAVULANATE POTASSIUM 42.9 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| USAntibiotics, LLC | AMOXICILLIN 125 mg/5mL; CLAVULANATE POTASSIUM 31.25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| USAntibiotics, LLC | AMOXICILLIN 250 mg/5mL; CLAVULANATE POTASSIUM 62.5 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| USAntibiotics, LLC | AMOXICILLIN 600 mg/5mL; CLAVULANATE POTASSIUM 42.9 mg/5mL | Jul 15, 2026 | Aug 31, 2026 |
| Micro Labs Limited | AMOXICILLIN 600 mg/5mL; CLAVULANATE POTASSIUM 42.9 mg/5mL | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Amoxicillin And Clavulanate Potassium — NDC 67296-1921-07," retrieved September 3, 2026, https://drugdashboards.com/drug/67296192107.
Free to cite with attribution — see how the data is put together.